• Biosimilar's Role in Improving Patient Access

  • Feb 27 2024
  • Length: 43 mins
  • Podcast

Biosimilar's Role in Improving Patient Access By cover art

Biosimilar's Role in Improving Patient Access

Listen for free

View show details

  • Summary

  • Biosimilars are entering the market at their fastest pace ever. In this episode, we interview a renowned health economist and an expert consultant in biosimilar distribution and patient support to explore the complex landscape of biosimilars, including examining the hurdles and breakthroughs in achieving acceptance by payers and providers and how best to improve patient access and affordability in a market dominated by established brands.

    Dr. Jason Shafrin, Senior Managing Director, Center for Healthcare Economics and Policy at FTI Consulting

    Marina Allen, SVP, Fingerpaint Market Access, Patient Support & Access Strategy Leader in Pharma-Biotech

    Biosimilars

    The Biologics Price Competition and Innovation Act of 2009

    PBMs (Pharmacy Benefit Managers)

    Medicare Advantage

    Humira (biosimilars)

    340B program

    Inflation Reduction Act

    Medicare Part D

    "brown bagging and white bagging"

    Mark Cuban (CostPlusDrugs)

    GoodRx

    average sales price (ASP)

    electronic health record (EHR) system

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    Show more Show less
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show more Show less

What listeners say about Biosimilar's Role in Improving Patient Access

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available